Stock Price Quote

INDRAPRASTHA MEDICAL CORPORATION LTD.

NSE : INDRAMEDCOBSE : 532150ISIN CODE : INE681B01017Industry : Hospital & Healthcare ServicesHouse : Apollo Hospitals
BSE394.75-15.6 (-3.8 %)
PREV CLOSE ( ) 410.35
OPEN PRICE ( ) 417.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 22838
TODAY'S LOW / HIGH ( )390.80 419.65
52 WK LOW / HIGH ( )155.55 571.95
NSE393.20-18.55 (-4.51 %)
PREV CLOSE( ) 411.75
OPEN PRICE ( ) 415.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 393.20 (540)
VOLUME 176946
TODAY'S LOW / HIGH( ) 390.05 422.95
52 WK LOW / HIGH ( )154.5 572
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 16-03 1988
Management Info
- Chairman Shivakumar Pattabhiraman - Managing Director
Registered Office

Address Sarita Vihar,Delhi - Mathura Road,,
New Delhi,
Delhi-110076

Phone 011- 26925858 / 26925801

Email imcl@apollohospitals.com

Website www.apollohospdelhi.com

Registrars Details
MUFG Intime India Pvt Ltd.
Noble Heights, 1st Floor, Plot NH 2,C-1 Block LSC, Near Savitri Market,Janakpuri,New Delhi
Listing : BSE, NSE

NEWS

04Feb Indraprastha Medical Corporation infor
Pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated..
14Jan Indraprastha Medical Corp informs abou
Pursuant to Regulation 30 read with Schedule III (Part A) of the SEBI (L..
06Jan Indraprastha Medical Corporation infor
Indraprastha Medical Corporation has informed that the Company has recei..
27Sep Indraprastha Medical Corporation infor
Pursuant to the provisions of the Code of Conduct for Prevention of Insi..
27Sep Indraprastha Medical Corporation infor
Pursuant to the provisions of the Code of Conduct for Prevention of Insi..

Financials

in Millions
QTR Dec 24 ANNUAL 24
Net Profit328.11239.6
Gross Profit 445.3 1661.1
Operating Profit 573.22102.5
Net Sales 3249.312447

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Max Healthcare Inst (BSE)
peergroup  1004.85 (0.40%)
M.Cap ( in Cr)97685.69
Asarfi Hospital Ltd. (BSE)
peergroup  93.63 (1.99%)
M.Cap ( in Cr)184.24
Gian Life Care (BSE)
peergroup  15.50 (2.38%)
M.Cap ( in Cr)16.03
KMC Speciality Hosp (BSE)
peergroup  69.36 (0.23%)
M.Cap ( in Cr)1131.16
Narayana Hrudayalay (BSE)
peergroup  1329.40 (0.01%)
M.Cap ( in Cr)27167.73

Shareholding Pattern

PROMOTERS 51%
NON-INSTITUTION 42.93%
MUTUAL FUNDS/UTI 2.65%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Indraprastha Medical Corporation Ltd.

Indraprastha Medical Corporation Ltd. was incorporated in the year 1988. Its today's share price is 394.75. Its current market capitalisation stands at Rs 3618.79 Cr. In the latest quarter, company has reported Gross Sales of Rs. 12447 Cr and Total Income of Rs.12615.9 Cr. The company's management includes Priya Ranjan, Vineeta Rai, Vinayak Chatterjee, Tejpreet Singh Chopra, Suneeta Reddy, Sangita Reddy, Sandip Somany, Salil Singhal, Menaka Guruswami, Mahesh Verma, Madhumita Ganguli, Arun Rai, Shivakumar Pattabhiraman, Prathap C Reddy.

It is listed on the BSE with a BSE Code of 532150 , NSE with an NSE Symbol of INDRAMEDCO and ISIN of INE681B01017. It's Registered office is at Sarita Vihar,Delhi - Mathura Road,New Delhi-110076, Delhi. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are SC Vasudeva & Co, SN Dhawan & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.